Literature DB >> 18438647

The effects of methamphetamine on core body temperature in the rat--part 2: an escalating regimen.

Benita J Myles1, Karen E Sabol.   

Abstract

RATIONALE: Methamphetamine (METH) induces hyperthermia, which is diminished with chronic treatment in a dose-dependent manner. Our objective was to determine whether the temperature responses produced by a chronic, escalating-dose METH regimen and a chronic, 5.0 mg/kg dose regimen.
METHODS: Rats received pretreatment injections of saline, 5.0 mg/kg METH, 10.0 mg/kg METH (second comparison group), or an escalating-METH regimen (2-9 mg/kg) for 12 days. On day 13, all four groups were challenged with 10.0 mg/kg METH. Temperature measurements were made telemetrically at 24 degrees C ambient temperature.
RESULTS: Escalating pretreatment produced hyperthermia; with successive exposures, the hyperthermic peak shifted to the right. The 5.0-mg/kg-pretreatment group initially showed no change in temperature at 60 min post-treatment but developed hypothermia at 60 min with chronic treatment; at 3 h post-treatment, significant hyperthermia was present and did not diminish with chronic treatment. After the 10.0-mg/kg-METH challenge, the saline-pretreatment group was hyperthermic, and the 10.0-mg/kg-pretreatment group was hypothermic; the 5.0 mg/kg and escalating pretreatment groups were intermediate and were not different from each other. At 3 h post-challenge, no group differences were apparent. Dopamine (DA) and serotonin (5-HT) were not depleted when measured 2 weeks after treatment ended.
CONCLUSIONS: (1) Escalating and 5.0-mg/kg regimens produced different temperature profiles during the 12-day pretreatment period but a similar diminished response to the 10.0-mg/kg-METH challenge on day 13. (2) The diminished temperature responses with chronic treatment occurred in the absence of long-term DA and 5-HT depletions.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18438647     DOI: 10.1007/s00213-007-1060-0

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  33 in total

1.  Tolerance to the neurotoxic effects of methamphetamine in young rats.

Authors:  Evan L Riddle; Jerry M Kokoshka; Diana G Wilkins; Glen R Hanson; Annette E Fleckenstein
Journal:  Eur J Pharmacol       Date:  2002-01-25       Impact factor: 4.432

2.  Cognitive performance of current methamphetamine and cocaine abusers.

Authors:  Sara L Simon; Catherine P Domier; Tiffanie Sim; Kimberly Richardson; Richard A Rawson; Walter Ling
Journal:  J Addict Dis       Date:  2002

3.  Long-term post-synaptic consequences of methamphetamine on preprotachykinin mRNA expression.

Authors:  Kamisha L Johnson-Davis; Glen R Hanson; Kristen A Keefe
Journal:  J Neurochem       Date:  2002-09       Impact factor: 5.372

Review 4.  Homeostatic theory of drug tolerance: a general model of physiological adaptation.

Authors:  C X Poulos; H Cappell
Journal:  Psychol Rev       Date:  1991-07       Impact factor: 8.934

5.  The physiologic, neurologic, and behavioral effects of caloric restriction related to aging, disease, and environmental factors.

Authors:  P H Duffy; J E Leakey; J L Pipkin; A Turturro; R W Hart
Journal:  Environ Res       Date:  1997       Impact factor: 6.498

6.  Elevated environmental temperature and methamphetamine neurotoxicity.

Authors:  Diane B Miller; James P O'Callaghan
Journal:  Environ Res       Date:  2003-05       Impact factor: 6.498

7.  Persistence of tolerance to methamphetamine-induced monoamine deficits.

Authors:  Jonathan P Danaceau; Cassandra E Deering; Jayme E Day; Stacy J Smeal; Kamisha L Johnson-Davis; Annette E Fleckenstein; Diana G Wilkins
Journal:  Eur J Pharmacol       Date:  2006-12-01       Impact factor: 4.432

Review 8.  Effect of chronic caloric restriction on physiological variables related to energy metabolism in the male Fischer 344 rat.

Authors:  P H Duffy; R J Feuers; J A Leakey; K Nakamura; A Turturro; R W Hart
Journal:  Mech Ageing Dev       Date:  1989-05       Impact factor: 5.432

Review 9.  Structural and metabolic brain changes in the striatum associated with methamphetamine abuse.

Authors:  Linda Chang; Daniel Alicata; Thomas Ernst; Nora Volkow
Journal:  Addiction       Date:  2007-04       Impact factor: 6.526

10.  The effects of conditioning with amphetamine on the thermic effects of amphetamine and pentobarbital.

Authors:  R E Hinson; A Streather; G Cosburn
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  1991       Impact factor: 5.067

View more
  8 in total

1.  Methiopropamine and its acute behavioral effects in mice: is there a gray zone in new psychoactive substances users?

Authors:  Fabio De-Giorgio; Sabrine Bilel; Micaela Tirri; Raffaella Arfè; Claudio Trapella; Cristian Camuto; Federica Foti; Paolo Frisoni; Margherita Neri; Francesco Botrè; Matteo Marti
Journal:  Int J Legal Med       Date:  2020-05-01       Impact factor: 2.686

2.  The effects of methamphetamine on core body temperature in the rat--part 1: chronic treatment and ambient temperature.

Authors:  Benita J Myles; Lee Ann Jarrett; Susan L Broom; H Anton Speaker; Karen E Sabol
Journal:  Psychopharmacology (Berl)       Date:  2008-04-27       Impact factor: 4.530

3.  Methamphetamine and core temperature in the rat: ambient temperature, dose, and the effect of a D2 receptor blocker.

Authors:  Karen E Sabol; Danielle M Yancey; H Anton Speaker; Scott L Mitchell
Journal:  Psychopharmacology (Berl)       Date:  2013-06-04       Impact factor: 4.530

4.  Immediate and lasting effects of chronic daily methamphetamine exposure on activation of cells in hypothalamic-pituitary-adrenal axis-associated brain regions.

Authors:  Damian G Zuloaga; Lance A Johnson; Sydney Weber; Jacob Raber
Journal:  Psychopharmacology (Berl)       Date:  2015-11-02       Impact factor: 4.530

5.  Methamphetamine sensitization attenuates the febrile and neuroinflammatory response to a subsequent peripheral immune stimulus.

Authors:  J B Buchanan; N L Sparkman; R W Johnson
Journal:  Brain Behav Immun       Date:  2009-12-24       Impact factor: 7.217

6.  Impairment of brain endothelial glucose transporter by methamphetamine causes blood-brain barrier dysfunction.

Authors:  P M Abdul Muneer; Saleena Alikunju; Adam M Szlachetka; L Charles Murrin; James Haorah
Journal:  Mol Neurodegener       Date:  2011-03-22       Impact factor: 14.195

7.  Methamphetamine inhibits the glucose uptake by human neurons and astrocytes: stabilization by acetyl-L-carnitine.

Authors:  P M Abdul Muneer; Saleena Alikunju; Adam M Szlachetka; James Haorah
Journal:  PLoS One       Date:  2011-04-27       Impact factor: 3.240

8.  Human methamphetamine pharmacokinetics simulated in the rat: behavioral and neurochemical effects of a 72-h binge.

Authors:  Ronald Kuczenski; David S Segal; William P Melega; Goran Lacan; Stanley J McCunney
Journal:  Neuropsychopharmacology       Date:  2009-07-01       Impact factor: 7.853

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.